What is Veradermics 's operating cash flow?

Veradermics (MANE) reported operating cash flow of -$21.17M in Q1 2026.

How has Veradermics 's operating cash flow changed year-over-year?

Veradermics 's operating cash flow decreased by 59.0% year-over-year, from -$13.32M to -$21.17M.

What does operating cash flow mean?

Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.

Veradermics MANE Operating Cash Flow

Operating Cash Flow at other companies

Johnson & JohnsonJNJ

$2.51B-39.8%

Hims & Hers HealthHIMS

$89.36M-18.1%

OrganonOGN

$225M+200%

PVL

Palvella TherapeuticsPVLA

-$10.86M-60.5%

TTR

Turn Therapeutics Inc.TTRX

-$1.63M-448%

PTH

Pelthos Therapeutics Inc.PTHS

-$13.13M-1,977%

Other financials

Income statement

See full

Operating income-$29.9M-131%

Net income-$27.2M-120%

EPS (diluted)-$1.32+93.3%

Balance sheet

See full

Cash & equivalents$168.4M+419%

Total debt$4.0K—

Total equity$390.6M+744%

Total assets$397.4M—

Cash flow

See full

CapEx--100%

Free cash flow-$21.2M-58.7%

Valuation

See full

Market cap$5.22B+315%

Returns & leverage

See full

Return on equity-28.7%—

Current ratio59.1×—

Where this comes from

Reported directly by Veradermics in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: Veradermics ’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Veradermics 's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Veradermics 's operating cash flow?: Veradermics (MANE) reported operating cash flow of -$21.17M in Q1 2026.
How has Veradermics 's operating cash flow changed year-over-year?: Veradermics 's operating cash flow decreased by 59.0% year-over-year, from -$13.32M to -$21.17M.
What does operating cash flow mean?: Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.